Literature DB >> 22249491

Temozolomide for pediatric high-grade gliomas.

Roger J Packer1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22249491     DOI: 10.1007/s11910-012-0250-2

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


× No keyword cloud information.
  13 in total

1.  IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children's Oncology Group.

Authors:  Ian F Pollack; Ronald L Hamilton; Robert W Sobol; Marina N Nikiforova; Maureen A Lyons-Weiler; William A LaFramboise; Peter C Burger; Daniel J Brat; Marc K Rosenblum; Emiko J Holmes; Tianni Zhou; Regina I Jakacki
Journal:  Childs Nerv Syst       Date:  2010-08-20       Impact factor: 1.475

2.  Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group.

Authors:  Kenneth J Cohen; Richard L Heideman; Tianni Zhou; Emiko J Holmes; Robert S Lavey; Eric Bouffet; Ian F Pollack
Journal:  Neuro Oncol       Date:  2011-02-22       Impact factor: 12.300

Review 3.  Treatment of high-grade glioma in children and adolescents.

Authors:  T J MacDonald; D Aguilera; C M Kramm
Journal:  Neuro Oncol       Date:  2011-07-22       Impact factor: 12.300

4.  O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort.

Authors:  Ian F Pollack; Ronald L Hamilton; Robert W Sobol; Judith Burnham; Allan J Yates; Emiko J Holmes; Tianni Zhou; Jonathan L Finlay
Journal:  J Clin Oncol       Date:  2006-07-20       Impact factor: 44.544

5.  The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group.

Authors:  R Sposto; I J Ertel; R D Jenkin; C P Boesel; J L Venes; J A Ortega; A E Evans; W Wara; D Hammond
Journal:  J Neurooncol       Date:  1989-07       Impact factor: 4.130

6.  The influence of central review on outcome associations in childhood malignant gliomas: results from the CCG-945 experience.

Authors:  Ian F Pollack; James M Boyett; Allan J Yates; Peter C Burger; Floyd H Gilles; Richard L Davis; Jonathan L Finlay
Journal:  Neuro Oncol       Date:  2003-07       Impact factor: 12.300

7.  Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas.

Authors:  Halldora K Thorarinsdottir; Mariarita Santi; Robert McCarter; Elisabeth J Rushing; Robert Cornelison; Alessandra Jales; Tobey J MacDonald
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

8.  Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.

Authors:  J L Finlay; J M Boyett; A J Yates; J H Wisoff; J M Milstein; J R Geyer; S J Bertolone; P McGuire; J M Cherlow; M Tefft
Journal:  J Clin Oncol       Date:  1995-01       Impact factor: 44.544

Review 9.  Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist.

Authors:  Alberto Broniscer; Amar Gajjar
Journal:  Oncologist       Date:  2004

Review 10.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

View more
  1 in total

1.  Atypical anaplastic astrocytoma with unique molecular features and diffuse leptomeningeal spread in a child with long-term survival.

Authors:  Yasmin Aghajan; Denise M Malicki; Michael L Levy; John Ross Crawford
Journal:  BMJ Case Rep       Date:  2019-02-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.